Walleye Trading
TAK icon

Walleye Trading’s Takeda Pharmaceutical TAK Stock Holding History

Walleye Trading’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-27,062
Closed -$475K – 4694
2025
Q4 		$422K Buy
27,062
+21,264
+367% +$304K ﹤0.01% 2930
2025
Q3 		$84.9K Buy
+5,798
New +$86.1K ﹤0.01% 3781
2024
Q4 		– Sell
-76
Closed -$1.04K – 4655
2024
Q3 		$1.08K Buy
+76
New +$1.08K ﹤0.01% 3977
2024
Q2 		– Sell
-6,988
Closed -$92.5K – 4890
2024
Q1 		$97.1K Sell
6,988
-24,812
-78% -$361K ﹤0.01% 3783
2023
Q4 		$454K Sell
31,800
-120,504
-79% -$1.71M ﹤0.01% 3163
2023
Q3 		$2.36M Buy
+152,304
New +$2.36M 0.01% 1660
2020
Q1 		– Sell
-678,737
Closed -$13.4M – 4550
2019
Q4 		$13.4M Buy
678,737
+242,099
+55% +$4.63M 0.09% 204
2019
Q3 		$7.51M Sell
436,638
-131,831
-23% -$2.28M 0.06% 297
2019
Q2 		$10.1M Sell
568,469
-292,108
-34% -$5.32M 0.09% 195
2019
Q1 		$17.5M Buy
+860,577
New +$17.3M 0.14% 110

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Walleye Trading's TAK Position: Q1 2026 in Review

Walleye Trading sold out of Takeda Pharmaceutical (TAK) in Q1 2026, closing a stake of 27,062 shares — an estimated $475K sold.

Walleye Trading first reported a position in TAK in Q1 2019 and held it in 10 quarters. The position peaked at $17.5M in Q1 2019. 358 funds tracked by Wall St. Rank hold TAK as of Q1 2026.

  • Walleye Trading reported no remaining Takeda Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Walleye Trading sold 27,062 Takeda Pharmaceutical shares in Q1 2026, an estimated $475K.
  • Walleye Trading first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 10 quarters.
  • Walleye Trading's Takeda Pharmaceutical position peaked at $17.5M in Q1 2019.
  • 358 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.